Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: J Invest Dermatol. 2016 Mar 25;136(7):1429–1437. doi: 10.1016/j.jid.2016.03.019

Figure 3.

Figure 3

Mast cell deficiency decreases skin barrier function. The shaved backs of WT and Kit W-sh/W-sh mice were treated with OVA-Alexa 647 for 24h. Uptake of OVA was assessed by measuring the percentage of DCs (CD11c+ MHC-IIhi) that stained positive for Alexa 647 fluorescence. Dot plots (A) are representative from 2 independent experiments with similar results. Bar graph (B) represents the mean ± SEM of the percent positive cells. *Significantly different from WT, p < 0.05.

HHS Vulnerability Disclosure